See more : PT Teladan Prima Agro Tbk (TLDN.JK) Income Statement Analysis – Financial Results
Complete financial analysis of The Beauty Health Company (SKIN) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of The Beauty Health Company, a leading company in the Household & Personal Products industry within the Consumer Defensive sector.
You may be interested
- New Nordic Healthbrands AB (publ) (NNH.ST) Income Statement Analysis – Financial Results
- Xinjiang International Industry Co.,Ltd (000159.SZ) Income Statement Analysis – Financial Results
- Southern Missouri Bancorp, Inc. (SMBC) Income Statement Analysis – Financial Results
- Changbai Mountain Tourism Co., Ltd. (603099.SS) Income Statement Analysis – Financial Results
- DocGo Inc. (DCGOW) Income Statement Analysis – Financial Results
The Beauty Health Company (SKIN)
Industry: Household & Personal Products
Sector: Consumer Defensive
Website: https://www.beautyhealth.com
About The Beauty Health Company
The Beauty Health Company designs, develops, manufactures, markets, and sells aesthetic technologies and products worldwide. The company's flagship product includes HydraFacial that enhance the skin to cleanse, peel, exfoliate, extract, infuse, and hydrate the skin with proprietary solutions and serums. Its products also comprise Syndeo, a HydraFacial Delivery System designed to elevate every part of the treatment and connects providers to the consumer's preferences to create a more personalized experience; HydraFacial Nation App, an app that allows consumers to learn about their skin health, discover treatment options, and track their treatments over time; and Keravive, a treatment for scalp health. The company was founded in 1997 and is headquartered in Long Beach, California.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 397.99M | 365.88M | 260.09M | 119.09M | 166.62M | 112.31M |
| Cost of Revenue | 242.88M | 115.54M | 78.26M | 51.89M | 60.11M | 39.34M |
| Gross Profit | 155.11M | 250.34M | 181.83M | 67.20M | 106.51M | 72.98M |
| Gross Profit Ratio | 38.97% | 68.42% | 69.91% | 56.43% | 63.92% | 64.98% |
| Research & Development | 10.10M | 8.44M | 8.20M | 3.41M | 4.61M | 2.40M |
| General & Administrative | 131.43M | 106.10M | 98.69M | 30.65M | 26.66M | 17.77M |
| Selling & Marketing | 144.50M | 160.08M | 111.58M | 50.32M | 61.77M | 42.74M |
| SG&A | 275.93M | 266.18M | 210.27M | 80.97M | 88.44M | 60.51M |
| Other Expenses | 0.00 | -1.65M | -51.55M | -47.00K | 535.00K | -9.00K |
| Operating Expenses | 286.03M | 274.62M | 218.47M | 84.38M | 93.05M | 62.92M |
| Cost & Expenses | 528.91M | 390.16M | 296.73M | 136.27M | 153.16M | 102.25M |
| Interest Income | 23.17M | 9.18M | 39.00K | 21.28M | 17.09M | 0.00 |
| Interest Expense | 13.65M | 13.39M | 11.78M | 21.28M | 17.09M | 10.05M |
| Depreciation & Amortization | 34.68M | 22.02M | 21.14M | 14.40M | 13.74M | 11.50M |
| EBITDA | -56.00M | 80.75M | -344.44M | -2.81M | 27.90M | 21.56M |
| EBITDA Ratio | -14.07% | -4.58% | -33.91% | -2.37% | 16.73% | 19.19% |
| Operating Income | -130.92M | -24.28M | -36.64M | -17.18M | 13.46M | 10.06M |
| Operating Income Ratio | -32.89% | -6.64% | -14.09% | -14.43% | 8.08% | 8.96% |
| Total Other Income/Expenses | 29.03M | 71.18M | -337.42M | -21.30M | -16.40M | -10.05M |
| Income Before Tax | -101.89M | 45.03M | -377.35M | -38.48M | -2.94M | 10.00K |
| Income Before Tax Ratio | -25.60% | 12.31% | -145.09% | -32.31% | -1.76% | 0.01% |
| Income Tax Expense | -1.77M | 648.00K | -2.24M | -9.31M | -1.30M | 327.00K |
| Net Income | -100.12M | 44.22M | -375.11M | -29.18M | -1.64M | -317.00K |
| Net Income Ratio | -25.16% | 12.09% | -144.22% | -24.50% | -0.98% | -0.28% |
| EPS | -0.76 | 0.30 | -3.67 | -0.85 | -0.05 | 0.00 |
| EPS Diluted | -0.76 | -0.23 | -3.67 | -0.85 | -0.05 | 0.00 |
| Weighted Avg Shares Out | 131.68M | 147.55M | 102.11M | 34.29M | 32.14M | 125.40M |
| Weighted Avg Shares Out (Dil) | 131.68M | 148.51M | 102.11M | 34.29M | 32.14M | 125.40M |
ROSEN, NATIONAL TRIAL LAWYERS, Encourages The Beauty Health Company Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action - SKIN
NEW YORK , Dec. 25, 2023 /PRNewswire/ -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of The Beauty Health Company (NASDAQ: SKIN) between May 10, 2022 and November 13, 2023, both dates inclusive...
SHAREHOLDER ACTION ALERT: The Schall Law Firm Encourages Investors in The Beauty Health Company with Losses of $100,000 to Contact the Firm
LOS ANGELES, CA / ACCESSWIRE / December 24, 2023 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against The Beauty Health Company ("BeautyHealth" or "the Company") (NASDAQ:SKIN) for violations of...
FINAL DEADLINE APPROACHING: The Schall Law Firm Encourages Investors in The Beauty Health Company with Losses to Contact the Firm
LOS ANGELES, CA / ACCESSWIRE / December 22, 2023 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against The Beauty Health Company ("BeautyHealth" or "the Company") (NASDAQ:SKIN) for violations of...
BEAUTY HEALTH INVESTOR DEADLINE APPROACHING: Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In Beauty Health To Contact Him Directly To Discuss Their Options
If you suffered losses exceeding $50,000 investing in Beauty Health securities between May 10, 2022 and November 13, 2023 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext....
INVESTOR ACTION DEADLINE: The Schall Law Firm Encourages Investors in The Beauty Health Company with Losses to Contact the Firm
LOS ANGELES, CA / ACCESSWIRE / December 21, 2023 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against The Beauty Health Company ("BeautyHealth" or "the Company") (NASDAQ:SKIN) for violations of...
SKIN Investors Have Opportunity to Lead The Beauty Health Company Securities Fraud Lawsuit
LOS ANGELES , Dec. 19, 2023 /PRNewswire/ -- Glancy Prongay & Murray LLP ("GPM") announces that investors with substantial losses have opportunity to lead the securities fraud class action lawsuit against The Beauty Health Company ("Beauty Health" or the "Company")...
SHAREHOLDER ALERT: Levi & Korsinsky Notifies The Beauty Health Company(SKIN) Investors of a Class Action Lawsuit and Upcoming Deadline
NEW YORK , Dec. 19, 2023 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in The Beauty Health Company ("Beauty Health" or the "Company") (NASDAQ: SKIN) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses...
INVESTOR ACTION NOTICE: The Schall Law Firm Encourages Investors in The Beauty Health Company with Losses to Contact the Firm
LOS ANGELES, CA / ACCESSWIRE / December 19, 2023 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against The Beauty Health Company ("BeautyHealth" or "the Company") (NASDAQ:SKIN) for violations of...
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of The Beauty Health Company - SKIN
NEW YORK , Dec. 18, 2023 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of The Beauty Health Company ("Beauty Health" or the "Company") (NASDAQ: SKIN). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext.
DEADLINE ACTION NOTICE: The Schall Law Firm Encourages Investors in The Beauty Health Company with Losses to Contact the Firm
LOS ANGELES, CA / ACCESSWIRE / December 18, 2023 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against The Beauty Health Company ("BeautyHealth" or "the Company") (NASDAQ:SKIN) for violations of...
Source: https://incomestatements.info
Category: Stock Reports